Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease

Publisher： Karger

E-ISSN： 1660-3818|39|4|246-252

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.39, Iss.4, 2012-07, pp. : 246-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease

By  

Transfusion Medicine and Hemotherapy, Vol. 35, Iss. 1, 2007-12 ,pp. : 18-23

Karger

Access to resources Recommend Favorite

Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresis

By Schwartz David   Ferguson John R.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2715-2728

Informa Healthcare

Access to resources Recommend Favorite

Granulocyte and monocyte adsorption apheresis for paradoxical reaction to infliximab

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 4, 2015-04 ,pp. : 438-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors associated with thiopurine non‐adherence in patients with inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 9, 2013-11 ,pp. : 1097-1108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of neutrophilic dermatosis in patient with Crohn's disease with granulocyte and monocyte adsorption apheresis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 8, 2015-08 ,pp. : 836-837

John Wiley & Sons Inc

Access to resources Recommend Favorite